Tirzepatide 10mg Lyophilized Powder

Tirzepatide 10mg Lyophilized Powder is a high-purity lyophilized powder raw material prepared by our factory based on solid-phase peptide synthesis technology. As a dual-target peptide structure targeting both GIP and GLP-1, Tirzepatide has received widespread attention in metabolic research. Its molecular sequence incorporates an Aib (α-aminoisobutyric acid) modification to enhance structural stability and extends half-life through a C20 fatty acid side chain. Our Tirzepatide 10mg Lyophilized Powder uses a vacuum freeze-drying process that maximally preserves the peptide's biological activity and structural integrity. The finished product is a white loose powder yielding a clear solution upon reconstitution.

 

We have accumulated over 20 years of hands-on experience in peptide synthesis. Every batch of Tirzepatide 10mg Lyophilized Powder undergoes closed-loop production entirely within a Class 10,000 cleanroom, from amino acid charging, solid-phase coupling, cleavage to chromatographic purification, sterile filtration, and lyophilization filling. Our independent QC laboratory conducts HPLC testing, molecular weight confirmation, and microbial limit testing on each batch to ensure consistent inter-batch quality and controllable impurities. The product primarily serves research institutions, biotechnology companies, and cosmetic raw material purchasers, for in vitro research, formulation development, and analytical standard preparation.

• In vitro scientific research in metabolism and endocrinology
• Peptide analytical method development and standard preparation
• Cell experiments and receptor binding studies in biotechnology laboratories
• Preliminary screening and stability testing of cosmetic raw material formulations

Our factory has over 20 years of technical accumulation in peptide synthesis and production, covering a total area of 25,000 square meters, with a core production area of a Class 100,000 GMP cleanroom (12,000 sqm), equipped with independent R&D laboratories, quality control testing centers, and raw material storage areas. The factory employs 118 people, including 25 R&D technicians, 35 QC inspectors, and 58 production workers. We have established an integrated fully automated solid-phase peptide synthesis production line using a closed production mode with automatic temperature and pH control, covering the entire process from amino acid charging, solid-phase synthesis, crude cleavage, chromatographic purification, desalting/concentration, sterile filtration, vacuum lyophilization to aseptic filling. The production line supports laboratory-scale R&D, pilot-scale amplification, and large-scale industrial mass production, with a stable monthly capacity of over 30,000 vials, and multiple GMP lines can be scheduled in parallel to ensure on-time delivery of large orders.

We follow GMP standards to control the entire production process, testing relevant indicators at raw material, semi-finished, and finished product nodes. Each batch comes with a COA report, 100% full inspection before packaging, and third-party inspection is supported. Under agreed storage conditions, unopened and correctly stored by the customer, we provide free replacement or refund for quality non-compliance caused by production processes.

The product uses inner sealed vials, outer shock-absorbing foam, and reinforced cartons for transportation, effectively reducing breakage risk during long-distance shipping. We support DDP terms and provide multi-channel logistics covering spot, bulk, and cross-border customized shipments. Each order comes with complete qualification documents including COA reports. After shipment, tracking numbers are synced and status continuously updated for full traceability.